Learn About Cholangiocarcinoma (Bile Duct Cancer)

What is the definition of Cholangiocarcinoma (Bile Duct Cancer)?

Cholangiocarcinoma (CCA) is a rare cancerous (malignant) growth in one of the ducts that carries bile from the liver to the small intestine.

What are the alternative names for Cholangiocarcinoma (Bile Duct Cancer)?

Bile duct cancer

What are the causes of Cholangiocarcinoma (Bile Duct Cancer)?

The exact cause of CCA isn't known. However, many of these tumors are already quite advanced by the time they are found.

CCA may start anywhere along the bile ducts. These tumors block off the bile ducts.

Both men and women are affected. Most people are older than 65.

People with the following health problems may have a higher chance of developing CCA:

  • Bile duct (choledochal) cysts
  • Chronic biliary and liver inflammation
  • History of infection with parasitic worms, liver flukes
  • Primary sclerosing cholangitis
  • Ulcerative colitis
What are the symptoms of Cholangiocarcinoma (Bile Duct Cancer)?

Symptoms of CCA may include any of the following:

  • Fever and chills
  • Clay-colored stools and dark urine
  • Itching
  • Loss of appetite
  • Pain in the upper right abdomen that may radiate to the back
  • Weight loss
  • Yellowing of the skin (jaundice)
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Cholangiocarcinoma (Bile Duct Cancer)?

The goal is to treat the cancer and the blockage it causes. When possible, surgery to remove the tumor is the treatment of choice and may result in a cure. Often the cancer has already spread locally or to another area of the body by the time it is diagnosed. As a result, surgery to cure the cancer is not possible.

Chemotherapy or radiation may be given after surgery to decrease the risk of the cancer returning.

In select cases, a liver transplant can be tried.

Endoscopic therapy with stent placement can temporarily relieve blockages in the biliary ducts. This may also relieve jaundice when the tumor cannot be removed.

Who are the top Cholangiocarcinoma (Bile Duct Cancer) Local Doctors?
General Surgery
General Surgery

Evansville Surgical Associates Inc

520 Mary St, 
Evansville, IN 
 61.5 mi
Accepting New Patients

Andrea Jester is a General Surgeon in Evansville, Indiana. Dr. Jester and is rated as an Advanced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). Her top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Gallbladder Disease, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Jester is currently accepting new patients.

The West Clinic, PLLC

1290 Kelley Dr, 
Paris, TN 
 97.7 mi
Accepting New Patients
Offers Telehealth

Kurt Tauer is an Oncologist in Paris, Tennessee. Dr. Tauer and is rated as an Advanced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, and Lung Cancer. Dr. Tauer is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Hematology Oncology | Oncology | Hematology
Hematology Oncology | Oncology | Hematology

Southeast Missouri Hospital Physicians LLC

1701 Lacey St, 
Cape Girardeau, MO 
 56.0 mi

Andrew Moore is a Hematologist Oncology specialist and an Oncologist in Cape Girardeau, Missouri. Dr. Moore and is rated as an Advanced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Lung Cancer, Lynch Syndrome, Colorectal Cancer, and Pleuropulmonary Blastoma.

What is the outlook (prognosis) for Cholangiocarcinoma (Bile Duct Cancer)?

Completely removing the tumor allows some people to survive with the possibility of complete cure.

The survival time varies greatly from several months to several years. Outlook depends on:

  • The location of CCA
  • The cell type of CCA
  • The stage of the tumor
  • The person's age and general health
  • Whether surgery is an option
  • The person's response to treatment

If the tumor cannot be completely removed, a cure is generally not possible. With treatment, about one half of affected people live a year, and about one half live longer, but rarely beyond 5 years. You and your family may want to start thinking about end-of-life planning, such as:

  • Palliative care
  • Hospice care
  • Advance care directives
  • Health care agents
What are the possible complications of Cholangiocarcinoma (Bile Duct Cancer)?

Complications of CCA include:

  • Infection
  • Liver failure
  • Spread (metastasis) of tumor to other organs
When should I contact a medical professional for Cholangiocarcinoma (Bile Duct Cancer)?

Contact your provider if you have jaundice or other symptoms of cholangiocarcinoma.

What are the latest Cholangiocarcinoma (Bile Duct Cancer) Clinical Trials?
Tumor, Normal Tissue and Specimens From Patients Undergoing Evaluation or Surgical Resection of Solid Tumors

Background: - Recent advances in cancer research have led to new therapies to treat the disease. It is important to continue these advances and discover new ones. To do that, researchers need tissue samples from solid tumors. This study will collect such samples from people already scheduled to have a procedure at the National Institutes of Health Clinical Center (NIHCC).

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase II Trial of Durvalumab With Gemcitabine and Cisplatin as Neoadjuvant Therapy for High-Risk Resectable Intrahepatic Cholangiocarcinoma

Summary: This phase II trial tests how well giving durvalumab with standard chemotherapy, gemcitabine and cisplatin, before surgery works in treating patients with high risk liver cancer (cholangiocarcinoma) that can be removed by surgery (resectable). Durvalumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as gemcitabine and cispl...

What are the Latest Advances for Cholangiocarcinoma (Bile Duct Cancer)?
Laparoscopic versus open hepatectomy for intrahepatic cholangiocarcinoma in patients aged 60 and older: a retrospective cohort study.
Tired of the same old research?
Check Latest Advances
Who are the sources who wrote this article ?

Published Date: June 17, 2024
Published By: Todd Gersten, MD, Hematology/Oncology, Florida Cancer Specialists & Research Institute, Wellington, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Gibson RN, Sutherland TR. The biliary system. In: Adam A, Dixon AK, Gillard JH, Schaefer-Prokop CM, eds. Grainger & Allison's Diagnostic Radiology. 7th ed. Philadelphia, PA: Elsevier; 2021:chap 24.

Koea JB. Intrahepatic cholangiocarcinoma. In: Jarnagin WR, ed. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas. 7th ed. Philadelphia, PA: Elsevier; 2023:chap 50.

National Cancer Institute website. Bile duct cancer (cholangiocarcinoma) treatment (PDQ) -- health professional version. www.cancer.gov/types/liver/hp/bile-duct-treatment-pdq. Updated March 28, 2024. Accessed December 2, 2024.

Rizvi SH, Gores GJ. Tumors of the bile ducts, gallbladder, and ampulla. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 11th ed. Philadelphia, PA: Elsevier; 2021:chap 69.